15
Participants
Start Date
May 12, 2011
Primary Completion Date
April 17, 2013
Study Completion Date
April 17, 2013
Replagal (agalsidase alfa)
0.2 mg/kg administered over 40 minutes every other week (EOW)
O & O Alpan LLC, Fairfax
Duke University Medical Center, Durham
Emory Division of Medical Genetics, Decatur
Baylor University Medical Center, Dallas
University of Utah Hospital, Salt Lake City
Lead Sponsor
Shire
INDUSTRY